Literature DB >> 23979044

The ratio of femoral head diameter to pelvic height in the normal hips of a Chinese population.

Yanbo Zhang1, Jinlan Jiang, Chenyu Wang, Jianlin Zuo, Modi Yang, Jincheng Wang.   

Abstract

OBJECTIVE: The aim of this study was to determine whether the ratio between the femoral head diameter and pelvic height in a Chinese population is the same as that found in Westerners.
MATERIALS AND METHODS: Standard pelvic radiography was performed on a group of 187 Chinese adult subjects consisting of 81 males and 106 females with a mean age of 40 years (21-68 years). Femoral head diameter (vertical distance from the femoral head-neck junction to the highest point of the femoral head) and pelvic height (vertical distance from the highest point of the iliac crest to the edge of the ischial tuberosities) were measured.
RESULTS: There were significant differences between males and females (p < 0.001), and between persons of high height versus low height (p = 0.011) and medium height (p = 0.039). There were no significant differences between persons of different age (p = 0.244), body mass index (p = 0.091), or between persons of low- and medium-height groups (p = 0.69). The overall mean ratio between the femoral head diameter and pelvic height was 0.215 (0.173-0.249) with a 95 % CI = 0.214-0.217. The mean ratios in males and females were 0.221 (0.194-0.249) and 0.211 (0.173-0.238), respectively.
CONCLUSION: The mean ratio in Chinese population was similar to the reported ratio in a western population (about 1:5). We suggest that Chinese surgeons may be able to use the Crowe classification to classify patients with hip dysplasia.

Entities:  

Mesh:

Year:  2013        PMID: 23979044     DOI: 10.1007/s00590-013-1298-7

Source DB:  PubMed          Journal:  Eur J Orthop Surg Traumatol        ISSN: 1633-8065


  45 in total

1.  The efficiency of the demarking point of the femoral head as a sex determining parameter.

Authors:  Samuel A Asala
Journal:  Forensic Sci Int       Date:  2002-06-25       Impact factor: 2.395

2.  Metric assessment of race from the pelvis in South Africans.

Authors:  M L Patriquin; M Steyn; S R Loth
Journal:  Forensic Sci Int       Date:  2002-06-25       Impact factor: 2.395

3.  Custom total hip arthroplasty in skeletal dysplasia.

Authors:  Liza Osagie; Mark Figgie; Mathias Bostrom
Journal:  Int Orthop       Date:  2011-07-13       Impact factor: 3.075

4.  Low friction arthroplasty for old untreated congenital dislocation of the hip.

Authors:  G Hartofilakidis; K Stamos; T T Ioannidis
Journal:  J Bone Joint Surg Br       Date:  1988-03

5.  Total hip replacement in congenital dislocation and dysplasia of the hip.

Authors:  J F Crowe; V J Mani; C S Ranawat
Journal:  J Bone Joint Surg Am       Date:  1979-01       Impact factor: 5.284

6.  The techniques of soft tissue release and true socket reconstruction in total hip arthroplasty for patients with severe developmental dysplasia of the hip.

Authors:  Xing Wu; Shao-hua Li; Lie-ming Lou; Zheng-dong Cai
Journal:  Int Orthop       Date:  2012-07-22       Impact factor: 3.075

7.  Total hip replacement with an uncemented Wagner cone stem for patients with congenital hip dysplasia.

Authors:  Raúl Torres Claramunt; Fernando Marqués; Alfonso León; Gemma Vilà; Carlos Mestre; Lluís Puig Verdié
Journal:  Int Orthop       Date:  2011-02-12       Impact factor: 3.075

8.  Treatment of high hip dislocation with a cementless stem combined with a shortening osteotomy.

Authors:  Ali Bulent Baz; Volkan Senol; Serdar Akalin; Ozkan Kose; Ferhat Guler; Adil Turan
Journal:  Arch Orthop Trauma Surg       Date:  2012-06-10       Impact factor: 3.067

9.  [Desmoid fibroma of the abdominal wall. Apropos of a case].

Authors:  B Martin; A Chevrot; M Wybier; F Gires; C Vallée; A Carlioz; A Dana; M Kerboull; G Pallardy
Journal:  J Radiol       Date:  1987-03

10.  Changes of gluteus medius muscle in the adult patients with unilateral developmental dysplasia of the hip.

Authors:  RuiYu Liu; XiaoDong Wen; ZhiQin Tong; KunZheng Wang; ChunSheng Wang
Journal:  BMC Musculoskelet Disord       Date:  2012-06-15       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.